Trøseid Marius; Arribas José R; Assoumou Lambert; Holten Aleksander Rygh; Poissy Julien; Terzić Vida; Mazzaferri Fulvia; Baño Jesús Rodríguez; Eustace Joe; Hites Maya; Joannidis Michael; Paiva José-Artur; Reuter Jean; Püntmann Isabel; Patrick-Brown Thale D J H; Westerheim Elin; Nezvalova-Henriksen Katerina; Beniguel Lydie; Dahl Tuva Børresdatter; Bouscambert Maude; Halanova Monika; Péterfi Zoltán; Tsiodras Sotirios; Rezek Michael; Briel Matthias; Ünal Serhat; Schlegel Martin; Ader Florence; Lacombe Karine; Amdal Cecilie Delphin; Kollaborációs szervezet: EU SolidAct study group; Hajdu Edit; et al. (kollab. közrem.):
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct) : a randomised, double-blind, placebo-controlled phase 3 trial.
CRITICAL CARE, 27 (1).
ISSN 1364-8535
(2023)